Schizotypal disorder

Discover the latest research on schizotypal disorder

Psychiatrist.com is a leading source for peer-reviewed research and evidence-based information on schizotypal disorder, schizophrenia and many other mental and neurologic illnesses.

Our vast collection of articles offers scientifically rigorous research about the latest developments in diagnosis and treatment of schizotypal personality disorder and other conditions. Content on the website includes articles, original research, studies, case reports, and meta-analyses on subjects related to schizotypal disorder and schizophrenia research, including information on disorganized schizophrenia, residual schizophrenia, undifferentiated schizophrenia, and psychotic schizophrenia.

Resources on Psychiatrist.com are designed for psychiatrists and mental health professionals, along with primary care physicians and other clinicians who treat patients with schizotypal disorder and other illnesses. Clinicians can also earn AMA PRA Category 1 Credits^TM with hundreds of CME activities provided by the CME Institute, a property of Physicians Postgraduate Press, Inc.

Register today for access to a wide range of benefits, or subscribe for complete access to all current and archived content on schizotypal disorder and other mental and CNS disorders.

Up-to-date research and articles on schizotypal disorder

Psychiatrist.com provides a deep compendium of research gathered from several sources, including The Journal of Clinical Psychiatry (JCP) and The Primary Care Companion for CNS Disorders (PCC).

Content on the website includes articles and research into many aspects of schizotypal disorder. Through case reports, brief reports, systematic reviews, commentaries, Academic Highlights, and clinical and practical psychopharmacology articles, you’ll encounter the most up-to-date and scientifically rigorous information concerning schizotypal personality disorder and other subjects.

Articles on schizotypal disorder and schizophrenia on Psychiatrist.com include titles such as:

• Olanzapine Plus Samidorphan (ALKS 3831) in Schizophrenia and Comorbid Alcohol Use Disorder: A Phase 2, Randomized Clinical Trial. Mary F. Brunette, Christoph U. Correll, Stephanie S. O’Malley, David McDonnell, Lauren DiPetrillo, Ying Jiang, Adam Simmons, Bernard L. Silverman, Leslie Citrome, and Alan I. Green
• Who Has the Ability to Consent?. La Vonne Ann Downey and Les Zun
• Long-Term Remission With Cariprazine Treatment in Patients With Schizophrenia: A Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Trial. Christoph U. Correll, Steven G. Potkin, Yan Zhong, Judit Harsányi, Balázs Szatmári, and Willie Earley

Earn CME credits at your convenience

Psychiatrist.com offers a convenient way to earn CME credits with research and activities related to schizotypal disorder. AMA PRA Category 1 Credits^TM are offered through the CME Institute (CMEInstitute.com), which is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Psychiatrist.com and CMEInstitute.com allow you to earn CME credits at your own pace and to more easily fit CME activities into your busy schedule. With a MyCME account – a free online tool that’s available when you register on the website – you can start an activity at any time and return to finish it later. You can also keep record of your activity, complete posttests and evaluations, and print transcripts and certificates as soon as you have earned credits.

CME activities on Psychiatrist.com related to schizophrenia include titles such as:

• Prevalence and Impact of Relapse in Patients With Schizophrenia. John Lauriello
  What can you do to combat relapse in your patients with schizophrenia? Dr Lauriello discusses identifying and addressing a major contributor to relapse—nonadherence to antipsychotics..
• Early Recognition and Treatment of Tardive Dyskinesia in Patients With Mood Disorders and Schizophrenia. Joseph P. McEvoy and Daniel E. Kremens
  Review highlights from 2 experts’ presentations on identifying and treating tardive dyskinesia (TD). Quotes from actual patients with TD illustrate the embarrassment that they feel and show why even mild movements should be treated if patients are distressed by them..
• Current Treatment Options and Emerging Agents for Schizophrenia. Christoph U. Correll
  New treatments for schizophrenia may improve symptom domains other than positive symptoms and reduce adverse effects. Here, an expert summarizes data on approved and investigational agents..

FAQs on schizotypal disorder research

The benefits of registration and subscription

There are two ways to engage with the many resources on schizotypal disorder available on Psychiatrist.com.

A free registration on the website provides you with access to a great number of benefits. You can access supplements and certain free articles from The Journal of Clinical Psychiatry as well as the full text of articles from The Primary Care Companion for CNS Disorders. As a registered user, you can also earn credits with more than 150 CME activities available through the CME Institute, tracking your activity and documenting AMA PRA Category 1 Credits^TM earned with a MyCME account.

A paid JCP subscription provides you with complete access to all schizotypal disorder resources and research on Psychiatrist.com. As a subscriber, you can search the archives and view any article from the journal from 1997 to the present. You’ll also have access to articles and JCP weekly and to new issues of JCP the day they are released.

Stay current with Elerts and podcasts

Subscribe to Elerts and podcasts to stay on top of the latest schizotypal disorder research and advances in other psychiatric conditions.

Elerts, or electronic alerts, are emails that arrive in your inbox daily with notice of new research, articles, reports, and CME activities related to schizotypal disorder and many other conditions. Elerts also include the table of contents for upcoming issues of The Journal of Clinical Psychiatry and The Primary Care Companion.

Podcasts on Psychiatrist.com are a convenient way to get an overview of the contents of each issue of JCP and PCC. In a 15- to 25-minute podcast, you’ll get a summary of the articles in each issue, including highlights of findings that allow you to stay current with advances in diagnosis and treatment of many mental and CNS disorders.

About Psychiatrist.com

Physicians Postgraduate Press, Inc., is the owner and publisher of Psychiatrist.com. The website is dedicated to providing peer-reviewed, evidence-based scientific information on mental health topics for psychiatrists, mental health professionals, primary care physicians, and others who treat patients with mental and neurologic classes.

Articles on Psychiatrist.com are collected from three sources: The Journal of Clinical Psychiatry, The Primary Care Companion for CNS Disorders, and the CME Institute at CMEInstitute.com. Psychiatrist.com publishes articles that cover a comprehensive list of subjects, including catatonic schizophrenia; treating ADHD in women; diagnosing bipolar disorder; symptoms of vascular dementia; treating moderate major depressive disorder (MDD); managing major depressive disorder symptoms; diagnosing MDD according to DSM 5 major depressive disorder criteria; and many other topics related to general psychiatry.